| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 85366 |
NOTA-Bn-SCN-Aoc-BN(7-14)S-2-(4-异硫氰基苄基)-NOTA偶联BN(7-14) |
179 |
h |
2024-12-18 |
| 85367 |
CAS:2055048-57-0,Fmoc-PEG4-Ala-Ala-Asn-PAB ,芴甲氧羰基-四聚乙二醇-ALA-ALA ASN-PAB |
140 |
kx |
2024-12-18 |
| 85368 |
NH2-PEG3-C6-Cl,1261350-60-0 |
147 |
zyl |
2024-12-18 |
| 85369 |
MC-Val-Cit-PAB-PNP(CAS:159857-81-5) |
169 |
WYQ |
2024-12-18 |
| 85370 |
NOTA-HSA 大环配体NOTA偶联人血清白蛋白 |
129 |
h |
2024-12-18 |
| 85371 |
SPDP-Val-Cit-PAB-OH(N-琥珀酰亚胺基-3-(2-吡啶二硫)丙酸) |
111 |
WYQ |
2024-12-18 |
| 85372 |
鹿茸多肽脂质体,Velvet,antler,peptides,liposome,VAP-Lip,多功能载药脂质体定制服务 |
196 |
axc |
2024-12-18 |
| 85373 |
NOTA-西妥昔单抗-800CW NOTA-cetuximab-800CW |
131 |
h |
2024-12-18 |
| 85374 |
CAS:644981-35-1,Val-Cit-PAB-MMAE , ADC试剂 |
133 |
kx |
2024-12-18 |
| 85375 |
SPDP-Val-Cit-PAB-PNP,分子式:C33H39N7O9S2 |
154 |
WYQ |
2024-12-18 |
| 85376 |
Azido-PEG4-Ala-Ala-Asn(Trt)-PAB(CAS:2055042-67-4) |
198 |
WYQ |
2024-12-18 |
| 85377 |
负载黄芩苷脂质体的纳米纤维膜,BCL-LPs/PVA-CS,NFs,载药脂质体定制服务 |
234 |
axc |
2024-12-18 |
| 85378 |
Auristatin E(CAS:160800-57-7),澳瑞他汀E |
146 |
WYQ |
2024-12-18 |
| 85379 |
Amino-PEG10-C6 氨基-聚乙二醇10-C6 |
137 |
zyl |
2024-12-18 |
| 85380 |
2762519-08-2,endo-BCN-PEG4-Val-Cit-PAB-MMAE,(1R,8S,9S)-双环[6.1.0]壬-四聚乙二醇-VAL-CIT-PAB-MMAE |
125 |
kx |
2024-12-18 |
| 85381 |
MMAE(CAS:474645-27-7),一甲基澳瑞他汀E,Monomethyl auristatin E |
384 |
WYQ |
2024-12-18 |
| 85382 |
m-PEG1-C11-SH,117559-62-3,甲基-一聚乙二醇-C11-巯基 |
138 |
zyl |
2024-12-18 |
| 85383 |
CAS:1703768-74-4,Vipivotide tetraxetan Linker , ADC试剂 |
134 |
kx |
2024-12-18 |
| 85384 |
Thalidomide-O-Cn-NH2,沙利度胺-烷基链-氨基 |
148 |
zyl |
2024-12-18 |
| 85385 |
Mal-amido-PEG8-val-gly-PAB-OH CAS号:2353409-52-4 |
137 |
WYQ |
2024-12-18 |
| 85386 |
cas:1042435-35-7,2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-oxopropoxy)ethoxy)ethoxy)ethyl acrylate,ADC定制 |
274 |
wyh |
2024-12-18 |
| 85387 |
Fmoc-PEG4-Ala-Ala-Asn-PAB,CAS号:2055048-57-0 |
152 |
WYQ |
2024-12-18 |
| 85388 |
CAS:1116086-09-9,Fmoc-Phe -Lys(Trt)-PAB-PNP , ADC试剂 |
129 |
kx |
2024-12-18 |
| 85389 |
DBCO-C12-amine 二苯并环辛炔-C12-胺 |
123 |
zyl |
2024-12-18 |
| 85390 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB,CAS号:2055042-69-6 |
169 |
WYQ |
2024-12-18 |
| 85391 |
C14-494 Lipid B4 CAS:2639634-80-1 |
139 |
zyl |
2024-12-18 |
| 85392 |
NOTA-ZnPc缀合物 水溶性磺化锌酞菁缀合1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA) |
134 |
h |
2024-12-18 |
| 85393 |
cas:663598-66-1,NO2-SPP-sulfo,ADC定制 |
126 |
wyh |
2024-12-18 |
| 85394 |
Val-Cit-PAB-MMAE(CAS:644981-35-1) |
169 |
WYQ |
2024-12-18 |
| 85395 |
NOTA-D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-nhch 2ch3 NOTA-atbbn |
137 |
h |
2024-12-18 |
| 85396 |
MAL-tetra-EG-OPFP,ADC定制 |
166 |
kx |
2024-12-18 |
| 85397 |
MC-Val-Cit-PAB-MMAE(CAS:646502-53-6) |
151 |
WYQ |
2024-12-18 |
| 85398 |
Fmoc-Val-Cit-PAB-MMAE(CAS:1350456-56-2) |
112 |
WYQ |
2024-12-18 |
| 85399 |
NOTA-VHH-Za 融合蛋白VHH-Zag偶联双功能螯合剂NOTA |
146 |
h |
2024-12-18 |
| 85400 |
Py-ds-Prp-OSu, ADC试剂 |
215 |
kx |
2024-12-18 |
| 85401 |
MMA-NOTA 马来酰亚胺单酰胺缀合1,4,7-三氮杂壬烷-1,4,7-三酰基)三乙酸 |
168 |
h |
2024-12-18 |
| 85402 |
辣根过氧化氢酶-棕榈酸 HRP-C16 palmitic acid |
152 |
zyl |
2024-12-18 |
| 85403 |
CAS:187794-49-6,Boc-Gly-Gly-Phe-Gly-OH,叔丁酯-GLY-GLY-PHE-GLY-羟基 |
131 |
kx |
2024-12-18 |
| 85404 |
C18-PEG5000-NHS 活性酯PEG十八烷基 |
156 |
zyl |
2024-12-18 |
| 85405 |
cas:1006592-59-1,Propargyl-C8-amido-PEG2-NHS ester,ADC定制 |
125 |
wyh |
2024-12-18 |
| 85406 |
N-Hydroxysulfosuccinimide sodium(CAS:106627-54-7) |
131 |
WYQ |
2024-12-18 |
| 85407 |
Vipivotide tetraxetan Linker(CAS:1703768-74-4) |
107 |
WYQ |
2024-12-18 |
| 85408 |
CAS:2395887-69-9,Mal-PEG2-VCP-NB ,马来酰亚胺-二聚乙二醇-VAL-CIT-PAB-PNP 酯 |
119 |
kx |
2024-12-18 |
| 85409 |
MAC glucuronide linker-2(CAS:229977-57-5) |
121 |
WYQ |
2024-12-18 |
| 85410 |
cas:102814-00-6,(2S,2'S)-Bis(2,5-dioxopyrrolidin-1-yl) 4,4'-disulfanediylbis(2-acetamidobutanoate),ADC定制 |
121 |
wyh |
2024-12-18 |